Menu
SOPHiA GENETICS™ is excited to be a part of the American Association for Cancer Research annual meeting, held in person in Orlando, FL from April 14th-19th.
You will have the chance to chat with our experts at booth #123 and learn how our BioPharma solutions may be right for you.
Decentralization and Collective Intelligence: Pioneering a New Era in Precision Medicine
Sunday, April 16
1:30 - 2:30 pm
Exhibitor Spotlight Theatre E
Join us on a journey to revolutionize clinical research programs with decentralized collective intelligence. See decentralization in motion with the SOPHiA DDM™ Platform, designed to connect and integrate multimodal data from 750+ institutions across 70 countries. Learn how to unlock the platform’s potential to identify unmet needs, accelerate precision medicine development, and improve patient access to new therapies by securely sharing knowledge on a global scale. Discover how SOPHiA DDM™ continues to drive and accelerate the adoption of homologous recombination deficiency (HRD) analysis and our decentralized approach to MSK-ACCESS®.
Presented by: T. Scott Reid, PhD - VP, Global Head of Diagnostics
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
